Table 1 Examples of prescription-checking rules for intravenous drugs
Type | Irrational prescriptions | Prescription-checking rules and warnings |
|---|---|---|
Wrong solvent | Lansoprazole for injection/30 mg + 5% GS/100 mL Carboplatin injection/0.4 g + 10% GS/250 mL Homoharringtonine injection/2 mg + 0.9% NS/100 mL | 0.9% NS only 5% GS 250—00 mL only 5%or10%GS 250–500mlL |
Hepatocyte growth-promoting factor injection/120 mg + 0.9%NS/250 mL | GS only | |
Dacarbazine injection/0.6 g + 0.9% NS/250 mL | 5% GS 250–500 mL only | |
Incompatibility | Vitamin C injection/2 g + calcium aspartate injection/1.5 g Dexamethasone injection/3 mg + cefazedone sodium injection/0.5 g + 5% GS/100 mL | Incompatible Incompatible |
Vitamin C injection/2 g + riboflavin sodium phosphate injection | Affectthetherapeutic effect | |
Inappropriate concentration | Ribavirin injection/500 mg + 0.9% NS/250 mL 10% potassium chloride injection/10 mL + invert sugar injection/250 mL | ≤ 1 mg/mL ≤ 3 mL/100 mL |
Etoposide injection/150 mg + 0.9% NS/250 mL | ≤ 0.4 mg/mL | |
Inappropriate dosage | Propacetamolhydrochlorideinjection/4 g + 0.9% NS/100 mL Vinpocetine injection/60 mg + GS/250 mL | Adults (and children over 15 years old): 1–2 g/dose Adults: 20–30 mg/dose |
ademetionine1,4-butanedisulfonate injection/1.5g + 5% GS/250 mL | Adults: 0.5–1 g/dose | |
Route of administration | Mouse nerve growth factor injection/18 μg + 0.9% NS/100 mL Thymopentin injection/40 mg + 0.9% NS/100 mL | Intramuscular injection Hypodermic injection |